{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:49:46Z","timestamp":1789080586352,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["6901031 and 7101215"],"award-info":[{"award-number":["6901031 and 7101215"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperglycemia causes mitochondrial damage renal tubular cells, which contribute to the progression of diabetic kidney disease. However, the metabolic aberration of renal tubular cells in an hyperglycemic milieu has not been fully elucidated. In this study, human proximal renal tubular cell line (HK-2 cell) are incubated in glucose and mannitol at 5\u2009mM or 25\u2009mM. Cellular metabolome was determined by capillary electrophoresis time of flight mass spectrometer (CE-TOF\/MS) and capillary electrophoresis-triple quadrupole mass spectrometry (CE-QqQMS). A total of 116 metabolites were quantified. Principal component analysis (PCA) revealed excellent clustering of metabolomic changes for different treatment conditions, and exposure to glucose at 5 and 25\u2009mM lead to distinct metabolomic profiles as compared to samples treated with serum-free medium or mannitol as osmotic control. Hierarchical clustering analysis showed a number of characteristic changes in metabolic profile following exposure to 5\u2009mM or 25\u2009mM glucose. Notably, lactate-to-pyruvate ratio was significantly increased, while cellular levels of citric acid, \u03b1-ketoglutaric acid (i.e. 2-oxoglutaric acid), and fumaric acid were significantly reduced after exposure to glucose at 25\u2009mM but not 5\u2009mM. Moreover, cellular levels of reduced glutathione and total glutathione were significantly decreased, and S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) ratio was significantly increased after exposure to glucose 25\u2009mM but not 5\u2009mM. We conclude that in response to high glucose, HK-2 cells characteristic metabolomic changes, including increase in lactate-to-pyruvate ratio, reduction in Krebs cycle metabolites, reduction in glutathione antioxidant activity, and increase in cellular methylation potential. Our results may shed light on the pathogenesis of diabetic kidney disease, but the expression of glucose metabolism-related protein and enzyme activity in HK-2 cells after hyperglycemia condition need to be confirmed by further studies.<\/jats:p>","DOI":"10.1038\/s41598-019-53214-1","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T11:03:18Z","timestamp":1573556598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Metabolomic Changes of Human Proximal Tubular Cell Line in High Glucose Environment"],"prefix":"10.1038","volume":"9","author":[{"given":"Pascal Zhongping","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston Wing-Shing","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Kit-Chung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Bik","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy Choi-Wan","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Ming","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-8505","authenticated-orcid":false,"given":"Cheuk Chun","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"53214_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","volume":"316","author":"M Afkarian","year":"2016","unstructured":"Afkarian, M. et al. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988\u20132014. JAMA 316, 602\u2013610 (2016).","journal-title":"JAMA"},{"key":"53214_CR2","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990\u20132010. N. Engl. J. Med. 370, 1514\u20131523 (2014).","journal-title":"N. Engl. J. Med."},{"key":"53214_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","volume":"80","author":"R Singh","year":"2014","unstructured":"Singh, R., Kishore, L. & Kaur, N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol. Res. 80, 21\u201335 (2014).","journal-title":"Pharmacol. Res."},{"key":"53214_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/jdi.12655","volume":"9","author":"SJ Song","year":"2018","unstructured":"Song, S. J. et al. Trends in diabetic retinopathy and related medical practices among type 2 diabetes patients: Results from the National Insurance Service Survey 2006\u20132013. J. Diabetes. Investig. 9, 173\u2013178 (2018).","journal-title":"J. Diabetes. Investig."},{"key":"53214_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho, N. H. et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271\u2013281 (2018).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"53214_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders, H. J., Huber, T. B., Isermann, B. & Schiffer, M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat. Rev. Nephrol. 14, 361\u2013377 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"53214_CR7","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1053\/j.ajkd.2014.08.001","volume":"64","author":"KR Tuttle","year":"2014","unstructured":"Tuttle, K. R. et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am. J. Kidney Dis. 64, 510\u2013533 (2014).","journal-title":"Am. J. Kidney Dis."},{"key":"53214_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.hkjn.2013.03.005","volume":"15","author":"YW Ho","year":"2013","unstructured":"Ho, Y. W. et al. Hong Kong Renal Registry Report 2012. Hong Kong J. Nephrol. 15, 28\u201343 (2013).","journal-title":"Hong Kong J. Nephrol."},{"key":"53214_CR9","first-page":"219","volume":"103","author":"B Fern\u00e1ndez Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez Fern\u00e1ndez, B. et al. 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. Minerva. Med. 103, 219\u2013234 (2012).","journal-title":"Minerva. Med."},{"key":"53214_CR10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jfma.2018.02.007","volume":"117","author":"YC Lin","year":"2018","unstructured":"Lin, Y. C., Chang, Y. H., Yang, S. Y., Wu, K. D. & Chu, T. S. Update of pathophysiology and management of diabetic kidney disease. J. Formos. Med. Assoc. 117, 662\u2013675 (2018).","journal-title":"J. Formos. Med. Assoc."},{"key":"53214_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","volume":"21","author":"TW Tervaert","year":"2010","unstructured":"Tervaert, T. W. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21, 556\u2013563 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"53214_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/ki.2013.89","volume":"84","author":"JM Forbes","year":"2013","unstructured":"Forbes, J. M., Harris, D. C. & Cooper, M. E. Report on ISN Forefronts, Melbourne, Australia, 4-7 October 2012: tubulointerstitial disease in diabetic nephropathy. Kidney Int. 84, 653\u2013656 (2013).","journal-title":"Kidney Int."},{"key":"53214_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2018.9","volume":"14","author":"JM Forbes","year":"2018","unstructured":"Forbes, J. M. & Thorburn, D. R. Mitochondrial dysfunction in diabetic kidney disease. Nat. Rev. Nephrol. 14, 291\u2013312 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"53214_CR14","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/ndt\/gfx339","volume":"33","author":"PZ Wei","year":"2018","unstructured":"Wei, P. Z. et al. Urinary mitochondrial DNA level is an indicator of intra-renal mitochondrial depletion and renal scarring in diabetic nephropathy. Nephrol. Dial. Transplant. 33, 784\u2013788 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"key":"53214_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fphar.2017.00215","volume":"8","author":"J Michl","year":"2017","unstructured":"Michl, J., Bello, O., Kite, G. C., Simmonds, M. S. J. & Heinrich, M. Medicinally Used Asarum Species: High-Resolution LC-MS Analysis of Aristolochic Acid Analogs and In vitro Toxicity Screening in HK-2 Cells. Front. Pharmacol. 8, 215 (2017).","journal-title":"Front. Pharmacol."},{"key":"53214_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1021\/acs.jnatprod.5b00556","volume":"79","author":"J Michl","year":"2016","unstructured":"Michl, J. et al. LC-MS- and 1H NMR-Based Metabolomic Analysis and in Vitro Toxicological Assessment of 43 Aristolochia Species. J. Nat. Prod. 79, 30\u201337 (2016).","journal-title":"J. Nat. Prod."},{"key":"53214_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00592-017-1074-y","volume":"55","author":"C Rossi","year":"2018","unstructured":"Rossi, C. et al. Proteomic and metabolomic characterization of streptozotocin-induced diabetic nephropathy in TIMP3-deficient mice. Acta. Diabetol. 55, 121\u2013129 (2018).","journal-title":"Acta. Diabetol."},{"key":"53214_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/ki.2015.199","volume":"88","author":"HC Looker","year":"2015","unstructured":"Looker, H. C. et al. Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int. 88, 888\u2013896 (2015).","journal-title":"Kidney Int."},{"key":"53214_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000447954","volume":"44","author":"M Darshi","year":"2016","unstructured":"Darshi, M., Van Espen, B. & Sharma, K. Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer. Am. J. Nephrol. 44, 92\u2013103 (2016).","journal-title":"Am. J. Nephrol."},{"key":"53214_CR20","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.jdiacomp.2015.06.016","volume":"29","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y., Zhang, S. & Wang, G. Metabolomic biomarkers in diabetic kidney diseases\u2013A systematic review. J. Diabetes Complications. 29, 1345\u20131351 (2015).","journal-title":"J. Diabetes Complications."},{"key":"53214_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","volume":"85","author":"WC Stanley","year":"2005","unstructured":"Stanley, W. C., Recchia, F. A. & Lopaschuk, G. D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093\u20131129 (2005).","journal-title":"Physiol. Rev."},{"key":"53214_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13, 629\u2013646 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"53214_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1157-x","volume":"9","author":"R Qi","year":"2018","unstructured":"Qi, R. & Yang, C. Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury. Cell Death Dis. 9, 1126 (2018).","journal-title":"Cell Death Dis."},{"key":"53214_CR24","doi-asserted-by":"crossref","unstructured":"Sas, K. M., et al. Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease. J. Proteomics Bioinform. Suppl 14, 2 (2015).","DOI":"10.4172\/jpb.S14-002"},{"key":"53214_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1097\/01.ASN.0000064500.89551.76","volume":"14","author":"M Haneda","year":"2003","unstructured":"Haneda, M., Koya, D., Isono, M. & Kikkawa, R. Overview of glucose signaling in mesangial cells in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 1374\u20131382 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"53214_CR26","doi-asserted-by":"publisher","first-page":"F40","DOI":"10.1152\/ajprenal.00103.2010","volume":"300","author":"A Singh","year":"2011","unstructured":"Singh, A. et al. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am. J. Physiol. Renal Physiol. 300, F40\u2013F48 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"53214_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cca.2019.07.005","volume":"496","author":"PZ Wei","year":"2019","unstructured":"Wei, P. Z. & Szeto, C. C. Mitochondrial dysfunction in diabetic kidney disease. Clin. Chim. Acta 496, 108\u2013116 (2019).","journal-title":"Clin. Chim. Acta"},{"key":"53214_CR28","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1016\/j.bmcl.2017.08.002","volume":"27","author":"ZM Xiu","year":"2017","unstructured":"Xiu, Z. M., Wang, L. P., Fu, J., Xu, J. & Liu, L. 1-Acetyl-5-phenyl-1H-pyrrol-3-ylacetate: An aldose reductase inhibitor for the treatment of diabetic nephropathy. Bioorg. Med. Chem. Lett. 27, 4482\u20134487 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"53214_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41401-018-0043-5","volume":"40","author":"J He","year":"2019","unstructured":"He, J. et al. The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db\/db mice through metabolic modulation. Acta. Pharmacol. Sin. 40, 86\u201397 (2019).","journal-title":"Acta. Pharmacol. Sin."},{"key":"53214_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato, M. & Natarajan, R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat. Rev. Nephrol. 15, 327\u2013345 (2019).","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"53214_CR31","doi-asserted-by":"publisher","first-page":"pdb.prot087155","DOI":"10.1101\/pdb.prot087155","volume":"2016","author":"Lisa C. Crowley","year":"2016","unstructured":"Crowley, L. C., Marfell, B. J., Christensen, M. E. & Waterhouse, N. J. Measuring Cell Death by Trypan Blue Uptake and Light Microscopy. Cold Spring Harb. Protoc. 2016, https:\/\/doi.org\/10.1101\/pdb.prot087155 (2016).","journal-title":"Cold Spring Harbor Protocols"},{"key":"53214_CR32","doi-asserted-by":"publisher","first-page":"20813","DOI":"10.1074\/jbc.M114.575464","volume":"289","author":"H Makinoshima","year":"2014","unstructured":"Makinoshima, H. et al. Epidermal growth factor receptor (EGFR) signaling regulates global metabolic pathways in EGFR-mutated lung adenocarcinoma. J. Biol. Chem. 289, 20813\u201320823 (2014).","journal-title":"J. Biol. Chem."},{"key":"53214_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1021\/ac990976y","volume":"72","author":"T Soga","year":"2000","unstructured":"Soga, T. & Heiger, D. N. Amino Acid Analysis by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry. Anal. Chem. 72, 1236\u20131241 (2000).","journal-title":"Anal. Chem."},{"key":"53214_CR34","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1021\/pr034020m","volume":"2","author":"T Soga","year":"2003","unstructured":"Soga, T. et al. Quantitative Metabolome Analysis Using Capillary Electrophoresis Mass Spectrometry. J. Proteome. Res. 2, 488\u2013494 (2003).","journal-title":"J. Proteome. Res."},{"key":"53214_CR35","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1021\/ac020064n","volume":"74","author":"T Soga","year":"2002","unstructured":"Soga, T. et al. Simultaneous Determination of Anionic Intermediates for Bacillus subtilis Metabolic Pathways by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry. Anal. Chem. 74, 2233\u20132239 (2002).","journal-title":"Anal. Chem."},{"key":"53214_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","volume":"6","author":"M Sugimoto","year":"2010","unstructured":"Sugimoto, M., Wong, D. T., Hirayama, A., Soga, T. & Tomita, M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 6, 78\u201395 (2010).","journal-title":"Metabolomics"},{"key":"53214_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-109","volume":"7","author":"BH Junker","year":"2006","unstructured":"Junker, B. H., Klukas, C. & Schreiber, F. VANTED: A system for advanced data analysis and visualization in the context of biological networks. BMC Bioinformatics 7, 109 (2006).","journal-title":"BMC Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41598-020-57576-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53214-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53214-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T15:56:34Z","timestamp":1671292594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53214-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53214"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53214-1","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-020-57576-9","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"22 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was supported by the Chinese University of Hong Kong (CUHK) research accounts 6901031 and 7101215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare no other financial or non-financial conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16617"}}